COUGH ASSOCIATED WITH CAPTOPRIL AND ENALAPRIL

被引：207

作者：

COULTER, DM

EDWARDS, IR

机构：

来源：

关键词：

D O I：

10.1136/bmj.294.6586.1521

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1521 / 1523

页数：3

共 35 条

[1] A NEED FOR NEW CONVERTING ENZYME-INHIBITORS [J].

BALL, SG ;

ROBERTSON, JIS .

[2]

CARRUTHERS SG, 1986, CAN MED ASSOC J, V135, P217

[3]

CLELAND JGF, 1985, BRIT HEART J, V54, P305

[4]

COULTER DM, 1982, NZ FAM PHYS, V9, P13

[5]

COULTER DM, 1986, MONITORING DRUG SAFE, P119

[6]

CROMBIE A, 1986, NEW ZEAL MED J, V99, P503

[7] ENALAPRIL WORLDWIDE EXPERIENCE [J].

DAVIES, RO ;

IRVIN, JD ;

KRAMSCH, DK ;

WALKER, JF ;

MONCLOA, F .

DIBIANCO, R .

MEDICAL TOXICOLOGY AND ADVERSE DRUG EXPERIENCE, 1986, 1 (02) :122-141

[9]

Dollery C T, 1983, J Hypertens Suppl, V1, P155

[10]

EDWARDS CRW, 1985, LANCET, V1, P30